CD20/CD79a/PAX5/CD3-negative post-transplant lymphoma with aberrant actin and desmin co-expression-a potential differential diagnostic pitfall between PTLD and PTSMT

Ann Hematol. 2022 Apr;101(4):881-883. doi: 10.1007/s00277-021-04394-2. Epub 2022 Feb 18.

Authors

Jan-Theile Suhren¹, Jerome Schlué¹, Hans Kreipe¹, Kais Hussein²

Affiliations

¹ Institute of Pathology, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
² Institute of Pathology, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany. hussein@mvz-hhz.de.

No abstract available

Publication types

Letter

MeSH terms

Actins*
Antigens, CD20
CD79 Antigens
Desmin
Humans
Lymphoma*
PAX5 Transcription Factor / genetics

Substances

Actins
Antigens, CD20
CD79 Antigens
CD79A protein, human
Desmin
PAX5 Transcription Factor
PAX5 protein, human